-
Since January, the cumulative transaction turnover of the pharmaceutical industry has exceeded 10 billion, and Hengrui has "won the championship
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];Data show that as of January 15, a total of 1,871 large transactions have occurred in the A-share market since 2023, with a cumulative transaction volume of 2.
-
Have you ever been bothered by this kind of worm that "everyone shouts and beats" but can't? —Popular science
Time of Update: 2023-01-07
Edited and written by Yimaitong, please do not reprint without authorization Cryptoptera (Figure 1) is a species of beetle, and cryptoptera dermatitis is skin inflammation caused by contact with the s
-
More and more people are constipated, how to deal
Time of Update: 2022-11-05
Do patients with FC have psychiatric disorders, such as factitious disorder?Long-term prognosis for children with FC:A study by Professor Marc Benninga published in Pediatrics explores this.
Professor Marc Benninga focused on the diagnosis and treatment of functional constipation (FC) in children.
-
4 pharmaceutical enterprises with a performance of more than 5 billion yuan, the company increased by 319 times to become the "growth king
Time of Update: 2022-11-04
378 billion yuan According to the third-quarter results report released by WuXi AppTec, the company achieved operating income of RMB 28.
378 billion yuan According to the third-quarter results report released by WuXi AppTec, the company achieved operating income of RMB 28.
-
Local innovative pharmaceutical companies are ready to innovate and constantly break the monopoly of multinational pharmaceutical companies
Time of Update: 2022-10-31
In recent years, national policies to encourage pharmaceutical innovation, such as volume procurement and medical insurance negotiation, have gradually advanced, in this context, local innovative drugs aim at the unmet clinical demand prospects of domestic patients, increase R&D investment, accumulate innovation, focus on the research and development of more new drugs, and constantly break the monopoly of multinational pharmaceutical companies, bringing good news to patients.
-
Since the third quarter, investment and financing in the field of medical equipment have been hot, and the financing scale of some enterprises has exceeded 5 billion yuan
Time of Update: 2022-10-25
On October 14, Fujian Provincial Joint Procurement Center for Pharmaceuticals and Devices issued an announcement "Laparoscopic Cutting Kiss/Suture Instrument Medical Consumables Inter-provincial Alliance Centralized Procurement Announcement (No. 1)", the overall price reduction is relatively moderate, import manufacturers are expected to report the volume to be seized by domestic manufacturers, domestic substitution is expected to accelerate.
-
Analysis of the three major innovation directions of CAR-T therapy enterprises
Time of Update: 2022-10-20
October 10, 2022/eMedClub News/--At present, a total of 8 CAR-T products have been approved for marketing worldwide, of which 6 target CD19 and 2 target BCMA, all of which are indicated for hematolog
-
Latest Technology: Multifaceted Mechanisms of Paeoniflorin in the Treatment of Tumors
Time of Update: 2022-10-15
This study reviewed the research progress of paeoniflorin's anti-tumor effect and mechanism, in order to provide new ideas and theoretical basis for the further development and clinical application of paeoniflorin .
-
Science Bulletin published a team article by Professor Jin Hongfang Du Junbao of Peking University Hospital online How to distinguish between vasovagal syncope and psychosocuous pseudosynosis
Time of Update: 2022-09-28
Recently, Professor Jin Hongfang and Professor Du Junbao's team from the Department of Pediatrics of Peking University First Hospital published an online publication entitled "Vasovagal syncope or psychogenic pseudosyncope?" in science bulletin (impact factor 20.
-
Listed pharmaceutical companies launched a wave of mergers and acquisitions: more than 170 mergers and acquisitions during the year, with a total amount of nearly 50 billion yuan
Time of Update: 2022-08-30
Huadong Pharmaceutical announced on August 9 that its wholly-owned subsidiary, Sino-US Huadong, will invest a total of no more than 396 million yuan, and obtain 60% of the equity of Huaren Technology in the form of capital increase and share transfer, becoming its controlling shareholder.
-
A large number of children's drugs have been included in the priority review list
Time of Update: 2022-08-30
In April this year, the product was included in the list of priority review varieties on the grounds of "new varieties, dosage forms and specifications of children's drugs that meet the physiological characteristics of children" .
-
Yizumi donated 500,000 yuan of medical equipment to Shunde Hospital of Southern Medical University
Time of Update: 2022-08-21
In order to win the battle of epidemic prevention and control as soon as possible, since the first batch of medical equipment worth 416,000 yuan was donated by Yizumi on February 4, Yizumi quickly accelerated the preparation of follow-up materials At present, the prevention and control of the new crown pneumonia epidemic has entered a critical period.
-
FDA approves dual-targeted type 2 diabetes drug Mounjaro, which can help non-diabetic patients lose 22.5
Time of Update: 2022-08-11
com/story/5571833 Leave a comment here The FDA approved Eli Lilly's once-weekly dual GIP and GLP-1 receptor agonist Mounjaro (tirzepatide) to improve glycemic control in adults with type 2 diabetes .
-
65 pharmaceutical companies have received institutional attention, and many have received more than 200 institutional investigators
Time of Update: 2022-04-29
A number of companies have obtained more than 200 institutional investigators, including Mindray Medical, Junshi Bio, and Huadong Medicine .
-
PNAS: Bats promote virus transmission via salivary gland immunosuppressive toxin
Time of Update: 2022-04-29
A joint team led by Lai Ren, a researcher at the Kunming Institute of Zoology, Chinese Academy of Sciences, found that bats may promote virus residency and transmission through their salivary gland immunosuppressive toxins .
